Big Pharma - The Next Bailout.

Seaman AM. Hospital-acquired MRSA infection rates falling: CDC. Reuters. Mon Sep 16, 2013 4:45pm EDT. Accessed on Sep. 9, 1016 from http://www.reuters.com/article/us-hospital-mrsa-idUSBRE98F0X920130916

McNeill R, Nelson D, Abutaleb Y. ‘Superbug’ scourge spreads as U.S. fails to track rising human toll. Reuters. http://www.reuters.com/investigates/special-report/usa-uncounted-surveillance/

Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S; Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013 Nov 25;173(21):1970-8. doi: 10.1001/jamainternmed.2013.10423. http://archinte.jamanetwork.com/article.aspx?articleid=1738718

Data.Medicare.gov. Hospital Compare Data Sets. Data Acquisition Dates 10/1/2014 to 9/30/2015. The MRSA Hospital SIR is 0.93. Last accessed Sep. 11, 2016 from https://data.medicare.gov/data/hospital-compare

Landers T, Kavanagh KT. Is the Presidential Advisory Council on Combating Antibiotic Resistance missing opportunities? American Journal of Infection Control Am J Infect Control. 2016 Sep 2. pii: S0196-6553(16)30706-4. doi: 10.1016/j.ajic.2016.07.008. [Epub ahead of print] http://www.ajicjournal.org/article/S0196-6553(16)30706-4/fulltext

Burger D. The Ebola Crisis: Coordination of a Multi-Agency Response. Committee on Oversight and Government
Reform. U.S. House of Representatives. Oct. 24, 2014. Last accessed on Sep. 9, 2016 from
https://www.gpo.gov/fdsys/pkg/CHRG-113hhrg94053/html/CHRG-113hhrg94053.htm

Swanson A. Big pharmaceutical companies are spending far more on marketing than research. The Washington Post. Feb. 11, 2015. Accessed on Sep. 9, 2016 from https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-pharmaceutical-companies-are-spending-far-more-on-marketing-than-research/

CDC: 1 in 3 antibiotic prescriptions unnecessary. Press Release. Centers for Disease Control and Prevention. Accessed on Sep. 9, 1016 from http://www.cdc.gov/media/releases/2016/p0503-unnecessary-prescriptions.html

Ornstein C, Groeer, L, and Jones RG. Dollars for Docs. How Industry Dollars Reach Your Doctors. ProPublica. Accessed on Sep. 9, 1016 from https://projects.propublica.org/docdollars/

Ornstein C. Jones RG, Tigas M. Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds ProPublica. Accessed on Sep. 9, 1016 from https://www.propublica.org/article/doctors-who-take-company-cash-tend-to-prescribe-more-brand-name-drugs

DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin J, Dudley RA. Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Internal Medicine. The Wall Street Journal. Accessed on Sep. 9, 2016 from http://archinte.jamanetwork.com/article.aspx?articleid=2528290

Loftus P. Even Cheap Meals Influence Doctors’ Drug Prescriptions, Study Suggests The Wall Street Journal. Accessed on Sep. 9, 2016 from http://www.wsj.com/articles/even-cheap-meals-influence-doctors-drug-prescriptions-study-suggests-1466434801

Steinman MS, Schillinger D. Drug Detailing in Academic Medical Centers: Regulating for the Right Reasons, with the Right Evidence, at the Right Time. Am J Bioeth. 2010 Jan; 10(1): 21–23. Accessed on Sep. 9, 2016 from . http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940347/

Fugh-Berman A, Ahari S. Following the Script: How Drug Reps Make Friends and Influence Doctors. Plos Medicine. April 24, 2007 Accessed on Sep. 9, 2016 from f="http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0040150" target="_blank"> http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0040150

McKenna M. Pharma Industry Calls on Governments to Fund New Antibiotics. Germination. National Geogrpahic. Jan. 20, 2016. http://phenomena.nationalgeographic.com/2016/01/20/davos-declaration/

2016 White House Budege Factsheet
https://www.whitehouse.gov/the-press-office/2015/01/27/fact-sheet-president-s-2016-budget-proposes-historic-investment-combat-a “An increase of over $100 million at BARDA for the development of new antibiotic therapies and diagnostics.” “Support for FDA efforts to streamline the development pathway to facilitate treatment of patients with unmet medical needs.”